Halozyme, Inc.
| Use attributes for filter ! | |
| Stock price | HALO |
|---|---|
| Disclaimer | |
| Headquarters | San Diego |
| California | |
| United States | |
| Ceo | Helen I. Torley |
| Number of employees | 260 |
| General counsel | Harry J Leonhardt |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1046060 |
About Halozyme, Inc.
Halozyme Therapeutics is a U. S. biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships. The company was founded in 1998 and went public in 2004.
